Cargando…

Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study

BACKGROUND: Cardiovascular diseases and especially Acute Coronary Syndrome (ACS) constitute a major health issue impacting millions of patients worldwide. Being a leading cause of death and hospital admissions in many European countries including Spain, it accounts for enormous amounts of healthcare...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koufaki, Margarita-Ioanna, Fragoulakis, Vasileios, Díaz-Villamarín, Xando, Karamperis, Kariofyllis, Vozikis, Athanassios, Swen, Jesse J., Dávila-Fajardo, Cristina L., Vasileiou, Konstantinos Z., Patrinos, George P., Mitropoulou, Christina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249170/ https://www.ncbi.nlm.nih.gov/pubmed/37287029 http://dx.doi.org/10.1186/s40246-023-00495-3

Ejemplares similares

Adoption of Pharmacogenomic Testing: A Marketing Perspective
por: Koufaki, Margarita-Ioanna, et al.
Publicado: (2021)

Systematic review of economic evaluation studies in psychiatric pharmacogenomics
por: Mitropoulou, C., et al.
Publicado: (2021)

Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx)
por: Just, Katja Susanne, et al.
Publicado: (2017)

Genome-based therapeutic interventions for β-type hemoglobinopathies
por: Karamperis, Kariofyllis, et al.
Publicado: (2021)

Pharmacogenomic (PGx) Counseling: Exploring Participant Questions about PGx Test Results
por: Schmidlen, Tara, et al.
Publicado: (2020)

Pharmacy students’ attitudes and intentions of pursuing postgraduate studies and training in pharmacogenomics and personalised medicine
por: Makrygianni, Dimitra, et al.
Publicado: (2023)

Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries
por: Blagec, Kathrin, et al.
Publicado: (2022)

Examining key factors impact on health science students’ intentions to adopt genetic and pharmacogenomics testing: a comparative path analysis in two different healthcare settings
por: Koufaki, Margarita-Ioanna, et al.
Publicado: (2022)

Implementing pharmacogenomics decision support across seven European countries: The Ubiquitous Pharmacogenomics (U-PGx) project
por: Blagec, Kathrin, et al.
Publicado: (2018)

PGxO and PGxLOD: a reconciliation of pharmacogenomic knowledge of various provenances, enabling further comparison
por: Monnin, Pierre, et al.
Publicado: (2019)

HUGO Statement on Pharmacogenomics (PGx): Solidarity, Equity and Governance
Publicado: (2007)

PGxCorpus, a manually annotated corpus for pharmacogenomics
por: Legrand, Joël, et al.
Publicado: (2020)

Pharmacogenomics (PGx) Patient with Mixed Levels of Actionable Variant Evidence
por: Schuh, Michael J., et al.
Publicado: (2020)

Editorial: Population Pharmacogenomics (PGx): From Variant Identification to Clinical Implementation
por: Hiratsuka, Masahiro, et al.
Publicado: (2021)

Application of Economic Evaluation to Assess Feasibility for Reimbursement of Genomic Testing as Part of Personalized Medicine Interventions
por: Simeonidis, Stavros, et al.
Publicado: (2019)

Population Pharmacogenomics in Croatia: Evaluating the PGx Allele Frequency and the Impact of Treatment Efficiency
por: Matišić, Vid, et al.
Publicado: (2023)

Drug Use among Nursing Home Residents in Denmark for Drugs Having Pharmacogenomics Based (PGx) Dosing Guidelines: Potential for Preemptive PGx Testing
por: Vermehren, Charlotte, et al.
Publicado: (2020)

Pharmacogenomics polygenic risk score for drug response prediction using PRS-PGx methods
por: Zhai, Song, et al.
Publicado: (2022)

Integrating Next-Generation Sequencing in the Clinical Pharmacogenomics Workflow
por: Giannopoulou, Efstathia, et al.
Publicado: (2019)

Conference report: inaugural Pharmacogenomics Access & Reimbursement Symposium
por: Rogers, Sara L., et al.
Publicado: (2021)

PGx: Putting Peptides to BED
por: Askenazi, Manor, et al.
Publicado: (2015)

Cross-Comparison of Exome Analysis, Next-Generation Sequencing of Amplicons, and the iPLEX(®) ADME PGx Panel for Pharmacogenomic Profiling
por: Chua, Eng Wee, et al.
Publicado: (2016)

Pharmacometabolomics-aided Pharmacogenomics in Autoimmune Disease
por: Katsila, Theodora, et al.
Publicado: (2016)

Comparison of Multidrug Use in the General Population and among Persons with Diabetes in Denmark for Drugs Having Pharmacogenomics (PGx) Based Dosing Guidelines
por: Westergaard, Niels, et al.
Publicado: (2021)

Dose Optimization in Oncology Drug Development: The Emerging Role of Pharmacogenomics, Pharmacokinetics, and Pharmacodynamics
por: Papachristos, Apostolos, et al.
Publicado: (2023)

Additional Utility of Pharmacogenomics (PGx) Panel Testing in a CYP2D6 Normal Metabolizer with a History of Breast Cancer
por: Schuh, Michael J.
Publicado: (2019)

Evolution of HLA-B Pharmacogenomics and the Importance of PGx Data Integration in Health Care System: A 10 Years Retrospective Study in Thailand
por: Koomdee, Napatrupron, et al.
Publicado: (2022)

Drug Use in Denmark for Drugs Having Pharmacogenomics (PGx) Based Dosing Guidelines from CPIC or DPWG for CYP2D6 and CYP2C19 Drug–Gene Pairs: Perspectives for Introducing PGx Test to Polypharmacy Patients
por: Westergaard, Niels, et al.
Publicado: (2020)

Design and Anticipated Outcomes of the eMERGE-PGx Project: A Multi-Center Pilot for Pre-Emptive Pharmacogenomics in Electronic Health Record Systems
por: Rasmussen-Torvik, Laura J., et al.
Publicado: (2014)

Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics
por: Beitelshees, Amber L, et al.
Publicado: (2015)

Whole genome sequencing in pharmacogenomics
por: Katsila, Theodora, et al.
Publicado: (2015)

Prediction of Autoimmune Diseases by Targeted Metabolomic Assay of Urinary Organic Acids
por: Tsoukalas, Dimitris, et al.
Publicado: (2020)

Pharmacogenetics in the Treatment of Cardiovascular Diseases and Its Current Progress Regarding Implementation in the Clinical Routine
por: Dávila-Fajardo, Cristina Lucía, et al.
Publicado: (2019)

Editorial: Pharmacogenomics and ethnicity: Prevalence and clinical significance of pharmacogenomic biomarkers in indigenous and other populations
por: Patrinos, George P., et al.
Publicado: (2023)

PGxMine: Text mining for curation of PharmGKB
por: Lever, Jake, et al.
Publicado: (2020)

Development of the PGx‐Passport: A Panel of Actionable Germline Genetic Variants for Pre‐Emptive Pharmacogenetic Testing
por: van der Wouden, Cathelijne H., et al.
Publicado: (2019)

General considerations for integrating pharmacogenomics into mainstream medical practice
por: Patrinos, George P
Publicado: (2010)

Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE study
por: van der Wouden, Cathelijne H., et al.
Publicado: (2020)

6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy
por: Stojiljkovic, Maja, et al.
Publicado: (2012)

Genetic Polymorphisms Affecting Ranibizumab Response in High Myopia Patients
por: Blánquez-Martínez, David, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kn1913ipgu858337plch5qe99t